Carmell Capital Lease Obligations vs Short Long Term Debt Analysis
| CTCX Stock | 0.28 0.02 7.69% |
Carmell Therapeutics financial indicator trend analysis is way more than just evaluating Carmell Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Carmell Therapeutics is a good investment. Please check the relationship between Carmell Therapeutics Capital Lease Obligations and its Short Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Carmell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Carmell Stock please use our How to Invest in Carmell Therapeutics guide.
Capital Lease Obligations vs Short Long Term Debt
Capital Lease Obligations vs Short Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Carmell Therapeutics Capital Lease Obligations account and Short Long Term Debt. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Carmell Therapeutics' Capital Lease Obligations and Short Long Term Debt is 0.97. Overlapping area represents the amount of variation of Capital Lease Obligations that can explain the historical movement of Short Long Term Debt in the same time period over historical financial statements of Carmell Therapeutics, assuming nothing else is changed. The correlation between historical values of Carmell Therapeutics' Capital Lease Obligations and Short Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Lease Obligations of Carmell Therapeutics are associated (or correlated) with its Short Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt has no effect on the direction of Capital Lease Obligations i.e., Carmell Therapeutics' Capital Lease Obligations and Short Long Term Debt go up and down completely randomly.
Correlation Coefficient | 0.97 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Capital Lease Obligations
Carmell Therapeutics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Carmell Therapeutics asset purchases. For example, Carmell Therapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Carmell Therapeutics control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Short Long Term Debt
The total of a company's short-term and long-term borrowings.Most indicators from Carmell Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Carmell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Carmell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Carmell Stock please use our How to Invest in Carmell Therapeutics guide.Tax Provision is expected to grow at the current pace this year. Selling General Administrative is likely to drop to about 2.5 M in 2024
| 2010 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.5M | 3.7M | 889.3K | 844.9K | Depreciation And Amortization | 242.1K | 242.6K | 124.8K | 162.5K |
Carmell Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Carmell Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.